DYN
DYN
NASDAQ · Biotechnology

Dyne Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$20.89
+1.09 (+5.51%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 17 85%
Hold 3 15%
Sell 0 0%
Price Target
Analyst Price Target +368.5% upside
Low Target $76.65
Average Target $97.86
High Target $132.93
Current Price $20.89
Current
$20.89
Target
$97.86
$76.65 $97.86 avg $132.93
Scenario Analysis
Bear Case
$76.65
266.9%
Low target
Base Case
$97.86
+368.5%
Avg target
Bull Case
$132.93
+536.3%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$25.00
-16.4% from high
52-Week Low
$8.06
+159.2% from low
50-Day SMA
$18.16
+15.0% vs SMA
200-Day SMA
$14.91
+40.1% vs SMA
RSI (14)
28.7
Oversold
Target vs 52W High
$97.86
+291.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%